Sex-differences in [68Ga]Ga-DOTANOC biodistribution-Reference-Cited by-同舟云学术

Sex-differences in [68Ga]Ga-DOTANOC biodistribution

Published:2019-09 Issue: Volume:76-77 Page:15-20
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Leisser A.,Lukic K.,Nejabat M.,Wadsak W.,Mitterhauser M.,Mayerhöfer M.,Karnaikas G.,Raderer M.,Hacker M.,Haug A.R.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Molecular Medicine

Reference32 articles.

1. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands;Reubi;Eur J Nucl Med,2001

2. The value of (68)Ga-DOTATATE PET/CT in diagnosis and management of neuroendocrine tumors compared to current FDA approved imaging modalities: a review of literature;Mojtahedi;Am J Nucl Med Mol Imaging,2014

3. ENETS consensus guidelines update for gastroduodenal neuroendocrine neoplasms;Delle Fave;Neuroendocrinology,2016

4. Appropriate use criteria for somatostatin receptor PET imaging in neuroendocrine tumors;Hope;J Nucl Med,2018

5. Twins in spirit - episode I: comparative preclinical evaluation of [(68)Ga]DOTATATE and [(68)Ga]HA-DOTATATE;Schottelius;EJNMMI Res,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and tolerability of somatostatin analogues according to gender in patients with neuroendocrine tumors;Reviews in Endocrine and Metabolic Disorders;2023-12-05

2. Dose-Limiting Bone Marrow Toxicities After Peptide Receptor Radionuclide Therapy Are More Prevalent in Women Than in Men;Clinical Nuclear Medicine;2022-04-15

3. The Dependence of Renal 68Ga[Ga]-DOTATOC Uptake on Kidney Function and Its Relevance for Peptide Receptor Radionuclide Therapy with 177Lu[Lu]-DOTATOC;Diagnostics;2021-07-06

4. Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?;Trends in Endocrinology & Metabolism;2020-09

5. Radiosynthesis and clinical evaluation of ⁶⁸Ga-DOTANOC as somatostatin receptor positive benign sub-dural meningioma PET imaging agent;pakistan journal of pharmaceutical sciences;2020-05-01